Weiss Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Weiss Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.92M	Buy	+12,109	New	+$2.65M	0.03%	298

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Weiss Asset Management's JAZZ Position: Q2 2026 in Review

Weiss Asset Management opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 12,109 shares worth $2.92M. The stake represents 0.03% of the portfolio and ranks #298 among its holdings.

641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Weiss Asset Management held 12,109 shares of Jazz Pharmaceuticals worth $2.92M as of Q2 2026.
Jazz Pharmaceuticals was a new Weiss Asset Management position in Q2 2026.
Jazz Pharmaceuticals made up 0.03% of Weiss Asset Management's portfolio in Q2 2026, its #298 holding.
641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Weiss Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.